<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39">
 <label>39.</label>
 <mixed-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Wu</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Q</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <source>Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and Their Implications</source>. 
  <publisher-name>Preprint repository name</publisher-name> (
  <year>2020</year>). Available online at: 
  <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.03.30.20047365v2" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.medrxiv.org/content/10.1101/2020.03.30.20047365v2</ext-link> (accessed April 16, 2020).
 </mixed-citation>
</ref>
